Mr. Mansour to strengthen firm’s FDA regulatory capabilities and continue DC office growth
Washington DC, 1 June 2015 – Mayer Brown announced today that Mark Mansour has joined the firm’s Litigation & Dispute Resolution practice as a partner in Washington DC, where he will focus on federal Food and Drug Administration (FDA) regulatory matters. Previously, Mr. Mansour was a partner at Jones Day.
“Mark is highly regarded for his unparalleled public and private sector experience advising on US and international food and drug law matters, and we are thrilled to welcome him to the firm,” said Mike Lackey, leader of Mayer Brown’s global Litigation & Dispute Resolution practice. “Companies continue to confront a more complex regulatory environment, especially in regards to false advertising, products liability, and compliance and investigations. In particular, Mark’s experience in medical devices, pharmaceutical and food-related FDA regulatory counseling, and litigation adds a new dimension to our multidisciplinary team of litigators and will be an invaluable asset to our multinational clients.”
For more than two decades, Mr. Mansour has worked with clients in the food, pharmaceutical, medical device, dietary supplement, and cosmetic industries to develop and implement strategies for regulatory approvals, compliance and enforcement actions, crisis management, rulemaking, and public policy issues. He counsels corporations and organizations on how to negotiate effectively with government agencies in the US and in key global markets.
“I am very pleased and excited to join Mayer Brown,” said Mr. Mansour. “The strength and depth of our industry teams in all of the FDA-regulated sectors, in addition to our talented colleagues in so many key areas of the law, represents a welcome opportunity to provide full-spectrum, forward-thinking advice to our collective clients at a critical time for all of the key industries.”
Mr. Mansour is recognized as a pioneer in the development of regulatory strategies that address the need to manage approvals in the US and other international markets, along with promoting efforts to achieve regulatory harmonization. He has been actively involved with industry and government to achieve solutions to issues such as the regulation of biotechnology and nanotechnology. He is also active in domestic and international industry groups involving the key regulated industries and has taken a lead role in drafting industry comments in response to key rulemaking activities over the past 20 years.
Additionally, Mr. Mansour has assisted clients in managing numerous Federal Trade Commission (FTC) consumer protection matters. His FTC experience involves investigations, enforcement actions, negotiations and consent decrees, involving marketing, advertising, and privacy matters, as well as advertising disputes before the National Advertising Division. He has managed numerous major recalls since 1997, including products such as melamine, heparin, and peanut butter, among others.
Before entering private practice, Mr. Mansour served as assistant general counsel and director of global regulatory affairs with two of the world’s largest food companies, setting policies and global strategies on health and nutrition claims, fortification, packaging, food safety, FDA compliance, and removal of international regulatory and trade barriers. Earlier in his career, Mr. Mansour served as a staff member of the US House of Representatives.
“We are delighted to welcome such a dynamic and client-focused lawyer as Mark,” said Dan Masur, partner-in-charge of Mayer Brown’s Washington DC office. “His addition bolsters our firm’s FDA regulatory capabilities and reinforces the firm’s overall litigation offerings. Additionally, his arrival continues the growth of our DC office, which has added more than 30 first-rate lawyers in the last year.”
Mr. Mansour is a sought-after writer and speaker on food and drug law issues. He earned his JD and BS degrees from Georgetown University and his MA from Harvard University.
[table id=9 /]